Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts.
about
CHIP promotes Runx2 degradation and negatively regulates osteoblast differentiationThe Role of Bone Marrow Microenvironment in Governing the Balance between Osteoblastogenesis and AdipogenesisThe role of microRNAs in bone remodelingInvolvement of protein tyrosine phosphatases in adipogenesis: new anti-obesity targets?Osteoblast-adipocyte lineage plasticity in tissue development, maintenance and pathologyStochasticity and the molecular mechanisms of induced pluripotencyRegulation of osteoblastogenesis and bone mass by Wnt10bMicroRNAs in adipogenesis and as therapeutic targets for obesity.The PPARgamma-selective ligand BRL-49653 differentially regulates the fate choices of rat calvaria versus rat bone marrow stromal cell populations.Bone Marrow Adipose Tissue Deficiency Increases Disuse-Induced Bone Loss in Male Mice.Down-regulation of type I Runx2 mediated by dexamethasone is required for 3T3-L1 adipogenesis.A subset of osteoblasts expressing high endogenous levels of PPARgamma switches fate to adipocytes in the rat calvaria cell culture model.Therapeutic Implications of PPARgamma in Human Osteosarcoma.SIRT1 is a positive regulator of the master osteoblast transcription factor, RUNX2.miRNA-mediated functional changes through co-regulating function related genes.Downregulation of PPARγ by miR-548d-5p suppresses the adipogenic differentiation of human bone marrow mesenchymal stem cells and enhances their osteogenic potentialThe peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized ratsA novel PPARγ2 modulator sLZIP controls the balance between adipogenesis and osteogenesis during mesenchymal stem cell differentiationCo-culture with periodontal ligament stem cells enhances osteogenic gene expression in de-differentiated fat cellsUse of small interfering ribonucleic acids to inhibit the adipogenic effect of alcohol on human bone marrow-derived mesenchymal cellsRetinaldehyde dehydrogenase 1 deficiency inhibits PPARγ-mediated bone loss and marrow adiposity.MicroRNA-194 reciprocally stimulates osteogenesis and inhibits adipogenesis via regulating COUP-TFII expression.Regulation of bone mass by Wnt signaling.Intrinsic Sex-Linked Variations in Osteogenic and Adipogenic Differentiation Potential of Bone Marrow Multipotent Stromal CellsEmodin enhances osteogenesis and inhibits adipogenesisProliferation and differentiation of rat osteoporosis mesenchymal stem cells (MSCs) after telomerase reverse transcriptase (TERT) transfection.Structurally-diverse, PPARγ-activating environmental toxicants induce adipogenesis and suppress osteogenesis in bone marrow mesenchymal stromal cells.Fine-Tuning Reception in the Bone: PPARgamma and Company.Pathophysiological role of enhanced bone marrow adipogenesis in diabetic complications.Signaling networks that control the lineage commitment and differentiation of bone cells.Upregulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by repressing HDAC6 protein expression.Curcumin increases rat mesenchymal stem cell osteoblast differentiation but inhibits adipocyte differentiation.Loss of wnt/β-catenin signaling causes cell fate shift of preosteoblasts from osteoblasts to adipocytestrans-10,cis-12 conjugated linoleic acid promotes bone formation by inhibiting adipogenesis by peroxisome proliferator activated receptor-γ-dependent mechanisms and by directly enhancing osteoblastogenesis from bone marrow mesenchymal stem cells.PPARgamma2 Regulates a Molecular Signature of Marrow Mesenchymal Stem Cells.Tributyltin engages multiple nuclear receptor pathways and suppresses osteogenesis in bone marrow multipotent stromal cellsReciprocal Control of Osteogenic and Adipogenic Differentiation by ERK/MAP Kinase Phosphorylation of Runx2 and PPARγ Transcription Factors.Signaling and transcriptional regulation in osteoblast commitment and differentiationOsteoblast-targeted overexpression of TAZ increases bone mass in vivo.The free fatty acid receptor G protein-coupled receptor 40 (GPR40) protects from bone loss through inhibition of osteoclast differentiation.
P2860
Q24656900-C334C6E4-2363-4376-BB52-0938E95CE5ECQ26738893-E579D2DD-4D34-4568-B99E-9109D3B2CF88Q26799815-D30ACB99-785E-4C76-B204-24276481830DQ26827352-CF4E8D39-FF2A-428A-A279-8B4C20934825Q27010162-00145E48-48B0-42FE-BF31-0B0C2B430E53Q27300697-13246FD0-1D26-44ED-939F-3D76806F8D7DQ28509048-0893C468-8671-4199-9C2F-ECC4E24505E2Q30400205-FAF21852-ADC4-432E-9951-8C2E7BAC9518Q33351534-33FAC6EE-E321-4B4E-BB22-9C7B4463B1A5Q33556939-0D6D2F17-9E53-4721-8AF1-9866803F5A52Q33636577-3AF72E2D-078F-4954-9F01-844BA3063B12Q33644501-B13D79F7-CE7C-4704-8855-9F2BC8529E7FQ33674615-8DF442DD-2724-425E-A992-0C3EB6A84320Q33728626-890C92FB-1806-4A80-9CD2-EC8DE46AEF3AQ33735910-46568EF4-B02C-4C47-9266-FA8CAC428CC5Q33797094-6BD5EAF6-6FF0-475E-BC2E-06A26AA86E55Q33912894-4D4A2A5F-EAF9-40DD-B7D1-92E79B736D8DQ34153540-6AA18B5E-C4D3-4B6C-9BEC-8796E2041209Q34294952-6BF435AC-7065-483A-8C7F-0874460B3C0EQ34336984-27A055BB-C70C-4251-9EB4-66761A39200FQ34402668-6887A8A3-E2CA-47BF-A572-0A36899E7A1BQ34448771-47DC2415-657B-4D71-BF17-0AD719CE8ED5Q34576629-39035EAB-CB22-4909-ADAE-9DC779BA7F00Q35050135-B2EC304B-5134-4679-8BFB-101387D490F1Q35102217-F5FA5593-3FD8-43C3-8BD6-E89C19AE3202Q35239972-1F3F140C-BD86-4C83-AFFD-A4EE0D1577ADQ35528700-75E3DBCA-38D5-4079-8C32-D0608A8EF10EQ35606046-CC83B47A-5D09-4F54-BBDF-4FA1224EC08DQ35998796-3740D911-675C-48C6-AE5F-E4219ABE799FQ36082866-4982BFC4-85C2-4EDF-AD82-D8BC4BFCE909Q36181298-779628D8-DD8A-4E12-BBDE-39B7FDE8DE9CQ36303922-0A71C25D-C297-4001-9CCD-D4BFE37C8060Q36328528-83B7FCE5-8D92-4AA0-B54F-EA2F6C8D6A9AQ36351185-E92E2C1B-49F8-413D-868A-56C135016677Q36446012-7E10EDF6-4931-410A-BD1B-CD5BFF7E76CFQ36533766-51C8F5FC-1CD2-498A-889F-A07E6431CE3EQ36558095-B3B94C35-67CB-446A-B437-47365F6875C9Q36606452-38B64B12-51DE-4EAC-9438-899BF186271BQ36618804-4F083707-E64C-4A55-9964-06BD658A521EQ36647375-461BA3D9-FD83-43B7-9E49-3D212C4473DD
P2860
Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Activation of peroxisome proli ...... of osteocalcin in osteoblasts.
@en
type
label
Activation of peroxisome proli ...... of osteocalcin in osteoblasts.
@en
prefLabel
Activation of peroxisome proli ...... of osteocalcin in osteoblasts.
@en
P2093
P2860
P356
P1476
Activation of peroxisome proli ...... of osteocalcin in osteoblasts.
@en
P2093
Chan Soo Shin
Jeong Ah Kim
Kyong Soo Park
Min Jae Jeon
Sang Wan Kim
Seong Yeon Kim
Sung Hee Kwon
Sung-Woo Park
P2860
P304
23270-23277
P356
10.1074/JBC.M211610200
P407
P577
2003-04-18T00:00:00Z